Document Detail


Inflammatory bowel disease: perioperative pharmacological considerations.
MedLine Citation:
PMID:  21803957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The perioperative management of patients with inflammatory bowel disease is challenging given the altered immune system that results from a variety of biologic and immunomodulator therapies. Clinicians are often faced with challenges and complicated equations when deciding on the type and dose of medication. To understand the effect of these medications and review the evidence regarding the management of these medications in the perioperative setting, a PubMed-based literature search (January 1, 1960, through April 1, 2011) was conducted using the following search terms: perioperative management, risk, outcome, inflammatory bowel disease, ulcerative colitis, Crohn's disease, aminosalicylates, glucocorticoids, purine analogues, cyclosporine, methotrexate, biologic therapy, infliximab, and thromboembolism. The 414 articles identified were manually sorted to exclude those that did not address perioperative risk, outcomes, and medications in the abstracts, yielding 84 articles for review. Additional references were obtained from the citations within the retrieved articles. This review surveys the findings of the selected articles and presents guidelines and resources for perioperative medication management for patients with inflammatory bowel disease undergoing surgery.
Authors:
Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Related Documents :
2770577 - Postgraduate qualifications of british doctors.
14702767 - The role of program evaluation in medical education at the john a. burns school of medi...
7468587 - Human genetics teaching in u.s. medical schools.
8607927 - Cheating in medical school: a survey of second-year students at 31 schools.
23054327 - Real-world comorbidities and treatment patterns of patients with acromegaly in two larg...
8601117 - Guidelines for the prevention and treatment of infection in patients with an absent or ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Mayo Clinic proceedings     Volume:  86     ISSN:  1942-5546     ISO Abbreviation:  Mayo Clin. Proc.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-08-01     Completed Date:  2011-09-30     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  0405543     Medline TA:  Mayo Clin Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  748-57     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Gastrointestinal Agents / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Inflammatory Bowel Diseases / drug therapy*,  surgery*
Perioperative Care / methods*
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Gastrointestinal Agents; 0/Immunosuppressive Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia...
Next Document:  Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treat...